The National Science Advisory Board for Biosecurity will perform the review, which NIH says is unrelated to the ongoing debate over the pandemic’s origins. One theory is that the virus accidentally leaked from a laboratory in China, though a mounting body of evidence suggests the virus likely originated from live animals sold at a market in Wuhan.
Based on the review, the advisory committee will develop recommendations for NIH on which experiments will require special safety measures and which are too dangerous to perform.
“This is an appropriate time for us to undertake and ensure that our policies are allowing potential benefits of research while managing potential risks,” Lyric Jorgenson, PhD, acting associate director for science policy at NIH, told the Post. “This is around definitions of what should be in and what should be out.”
NIH said it hopes to have the new recommendations by the end of 2022.
View the full article here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
